Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC)

Published:2012-08 Issue:2 Volume:77 Page:306-311
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Erfani Nasrollah,Mehrabadi Shayesteh Mofakhami,Ghayumi Mohammad Ali,Haghshenas Mohammad Reza,Mojtahedi Zahra,Ghaderi Abbas,Amani Davar

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference43 articles.

1. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood;Jonuleit;J Exp Med,2001

2. Regulatory T cells: key controllers of immunologic self-tolerance;Sakaguchi;Cell,2000

3. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self;Sakaguchi;Nat Immunol,2005

4. Expression and function of CTLA-4 in Th1 and Th2 cells;Alegre;J Immunol,1998

5. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma;Liyanage;J Immunother,2006

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of tumour-associated regulatory T-cells as a biomarker in non-small cell lung cancer: a systematic review and meta-analysis;Systematic Reviews;2024-09-14

2. Significance of novel PANoptosis genes to predict prognosis and therapy effect in the lung adenocarcinoma;Scientific Reports;2024-09-09

3. A Mendelian randomization study of the causal relationships between immune cells and colorectal cancer;2024-05-08

4. FOXP3: A Player of Immunogenetic Architecture in Lung Cancer;Genes;2024-04-15

5. The relationship between immune-related adverse events during ipilimumab monotherapy and survival outcomes among melanoma patients: A systematic review;Journal of Oncology Pharmacy Practice;2024-04-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3